Degradation of dual proteins induced by “power train”
Journal of Pharmaceutical Analysis · 2026-10 · 16 (10) · 101639
DOI: 10.1016/j.jpha.2026.101639 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Analysis, 2026-10. Verfasst von Rui Liang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biomedical Analytics (Southwest University), Chongqing Science and Technology Bureau, College of Pharmaceutical Sciences, Southwest…. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
Targeted degradation of multiple oncogenic membrane proteins remains challenging due to inefficient lysosomal trafficking and off-target effects, which limits the application of current monovalent aptamer systems. To improve delivery efficiency and degradation efficacy, we developed a specific multivalent network "power train" probe based on rolling circle amplification (RCA) and lysosome-targeting chimera (LYTAC). The probe integrates three functional aptamers: cation-independent mannose-6-phosphate receptor (CI-M6PR) aptamer, responsible for lysosomal trafficking, functions as the "locomotive"; AS1411, which targets nucleolin (NCL), and Sgc8c, which binds to protein tyrosine kinase 7 (PTK7), act as the "carriages". This tri-aptamer configuration enables simultaneous degradation of both NCL and PTK7. Compared with linear probes, the efficiency of protein degradation is increased by 1.5-1.7 fold, and the enhancement of its cytotoxicity is significantly increased by 4.7-5.8 fold. This network structure's structure significantly improves binding affinity (the affinity of the network structure is 6.1-6.3 fold higher than that of monovalent aptamers) while enhancing lysosomal degradation efficiency. Removal of any single functional unit will reduce the efficacy of the probe. This "power train" exerts tumor-selective cytotoxicity through dual oncoprotein degradation by coordinately regulating CI-M6PR-mediated lysosomal targeting, AS1411-mediated NCL degradation, and Sgc8c-induced PTK7 degradation, thereby inducing apoptosis and inhibiting proliferation and migration of tumor cells.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Biomedical Analytics (Southwest University), Chongqing Science and Technology Bureau, College of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China.
- The Pharmacy Department of the Second Hospital of Chongqing Medical University, Chongqing, 400010, China.
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Liang, R., Nie, K., Lou, B., Liu, L., Wu, X., Tian, C., Liu, H., Huang, C., Li, D., & Li, C. (2026). Degradation of dual proteins induced by “power train”. Journal of Pharmaceutical Analysis, 16(10), 101639. https://doi.org/10.1016/j.jpha.2026.101639
Vancouver
Liang R, Nie K, Lou B, Liu L, Wu X, Tian C, et al. Degradation of dual proteins induced by “power train”. Journal of Pharmaceutical Analysis. 2026;16(10):101639. doi:10.1016/j.jpha.2026.101639
BibTeX
@article{Liang2026,
author = {Liang, Rui and Nie, Kunhan and Lou, Beibei and Liu, Lin and Wu, Xiaoqiao and Tian, Chun and Liu, Hui and Huang, Chengzhi and Li, Di and Li, Chunmei},
title = {Degradation of dual proteins induced by “power train”},
journal = {Journal of Pharmaceutical Analysis},
year = {2026},
volume = {16},
number = {10},
pages = {101639},
doi = {10.1016/j.jpha.2026.101639}
}
EUVIMED